| Literature DB >> 34517825 |
Ype de Jong1,2, Esmee M van der Willik3, Jet Milders3, Yvette Meuleman3, Rachael L Morton4, Friedo W Dekker3, Merel van Diepen3.
Abstract
RATIONALE &Entities:
Mesh:
Year: 2021 PMID: 34517825 PMCID: PMC8438879 DOI: 10.1186/s12882-021-02489-6
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Fig. 1Flowchart of study inclusion. Non-qualitative studies were excluded. Studies that did not contain patients with CKD, or were mixed with other participants and of which the data were not linkable to patients with CKD were marked as ‘wrong population’. Studies that did not contain extractable data (e.g. systematic reviews), but were qualitative and included patients with CKD were marked as ‘wrong study design’. The inclusion and labelling method is described in more detail in Supplement Item 1
Overview of included studies. Abbreviations: SD: standard deviation, CKD: Chronic Kidney Disease; KRT: kidney replacement therapy. aStudies with unspecified distribution CKD groups (e.g. “CKD 4-5 are marked as CKD 4 and CKD 5); +studies with eGFR ranges (e.g. “eGFR < 30″ are marked as CKD 4 and CKD 5) are attributed to a CKD stage according to the KDIGO CKD staging system; b mean; c median. An overview of the 20 studies that included a mixed population is presented in the supplement Table S1
| DEMOGRAPHY | CKD STAGE | RESEARCH METHODS | RESULTS | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | Country | n. | Age | Sex m/f | 1 | 2 | 3 | 4 | 5 | Predialysis | Unclear | Sampling | Data gathering | Analysis | Principal research aim |
| Andrew, J. 2001 [ | United Kingdom | 10 | – | – | x | Purposive | Interview (semi-structured) | Grounded theory | Needs and experiences of predialysis patients | ||||||
| Iles-Smith, H. 2005 [ | United Kingdom | 10 | 62b (range 37–73) | 8/2 | x | Consecutive | Interview (semi-structured) | – | Perceptions, expectations and experiences of predialysis patients | ||||||
| Tweed, A. E. 2005 [ | United Kingdom | 9 | 54b (range 29–69) | 5/4 | x | Convenience | Interview (semi-structured) | Phenomenology | Process of patient decision-making, perspectives and impact on life in predialysis patients | ||||||
| Costantini, L. 2008 [ | Canada | 14 | 41.3b (range 16–69) | 6/8 | x | x | x | Purposive | Interview (semi-structured) | Content analysis | Self-management, experiences and perceptions on health and support in CKD | ||||
| Sakraida, T. J. 2009 [ | USA | 6 | 58b (SD: 9.98) | 4/2 | x | x | Purposive | Focus group | Ethnography | Perceived resources for and barriers of self-management | |||||
| Noble, H. 2010 [ | United Kingdom | 30 | – | – | x | Consecutive | Observations, Interview | – | Symptoms in late stage CKD | ||||||
| de Brito-Ashurst, I. 2011 [ | United Kingdom | 20 | 60b (SD: 8) | 0/20 | x | Purposive | Focus group, Interview (structured) | – | Views on CKD diets and salt intake and barriers and facilitators of dietary change | ||||||
| Nygardh, A. 2012 [ | Sweden | 20 | 69c (range 38–86) | 14/6 | x | Purposive | Interview (unstructured) | Content analysis | How to empower patients with CKD | ||||||
| Sakraida, T. J. 2012 [ | USA | 6 | 58b (SD: 9.98) | 4/2 | x | Convenience | Focus group | Ethnography | Coping resources and barriers of self-management in CKD | ||||||
| Walker, R. 2012 [ | United Kingdom | 9 | 75.9b (range 63–93) | 4/5 | x | x | Purposive | Interview (semi-structured) | – | Experiences with adherence to behavioural changes in late stage CKD | |||||
| Johnston, S. 2012 [ | United Kingdom | 9 | 86b (range 74–96) | 4/5 | x | Convenience | Interview (semi-structured) | Grounded theory | Motivation to opt for conservative therapy in late-stage CKD | ||||||
| McKillop, G. 2013 [ | United Kingdom | 10 | 60b (range 29–82) | 5/5 | x | Purposive | Interview (semi-structured) | Thematic analysis | Views and motivations regarding adherence to medication | ||||||
| Lin, C. C. 2013 [ | Taiwan | 15 | - (range 25–77) | 12/3 | x | x | x | Purposive | Interview (semi-structured) | Content analysis | Illness representations and coping processes in early CKD | ||||
| Lopez-Vargas, P. A. 2014 [ | Australia | 38 | 54b (range 20–79) | 23/15 | x | x | x | x | x | Purposive | Focus group | Grounded theory | Experiences, perspectives and information needs in managing and living with CKD | ||
| Tangkiatkumjai, M. 2014 [ | Thailand | 16 | 62.5b (SD: 12.3) | 6/10 | x | x | x | – | Interview (structured) | Thematic analysis | Views on and reasons to use herbal and dietary supplements | ||||
| Clarke, A. L. 2015 [ | United Kingdom | 30 | FG: 68.6 (range 48–83); IV 64.1 (range 26–78) | FG: 7/6; IV: 11/6 | x | x | x | Convenience, purposive | Focus group, Interview (semi-structured) | Constructivist paradigm | Motivators, barriers and beliefs regarding physical exercise | ||||
| Erlang, A. S. 2015 [ | Denmark | 9 | - (range 37–86) | 7/2 | x | Convenience | Interview (semi-structured) | Phenomenology and hermeneutics | Perspectives, values and experiences related to involvement in the choice of dialysis modality | ||||||
| Shirazian, S. 2016 [ | USA | 23 | 64b (SD: -) | 14/9 | x | x | x | x | Purposive | Focus group | Thematic analysis | Views, barriers and supports to the self-management of CKD | |||
| Wright Nunes, J. 2016 [ | USA | 49 | 62b (SD: 14) | 24/25 | x | x | x | x | x | Purposive | Interview (semi-structured) | Grounded theory | Emotions after diagnosis, views on how diagnosis was communicated | ||
| Wu, C. C. 2016 [ | Taiwan | 15 | 52b (range 24–81) | 7/8 | x | x | Purposive | Interview (semi-structured) | Content analysis | Experiences and perceptions related to living with late-stage CKD | |||||
| Schipper, K. 2016 [ | The Netherlands | 41 | - (range 18–75) | 17/24 | x | x | Purposive | Interview (semi-structured), Focus group | Content analysis | Experience, needs and coping with CKD | |||||
| Bowling, C. B. 2017 [ | USA | 30 | 75.1b (range 70.1–90.7) | 29/1 | x | x | x | Convenience | Focus group | Grounded theory | Self-management and complexity of CKD | ||||
| Havas, K. 2017 [ | Australia | 63 | 56.9b (range 25–84) | 26/37 | x | x | x | x | Convenience | Interview (semi-structured) | Content analysis | Experiences, perceptions and suggestions on self-management support | |||
| Lovell, S. 2017 [ | New Zealand | 17 | 75.1b (range 66–90) | 14/3 | x | Purposive | Interview (semi-structured) | Content analysis | Perspectives of progression of CKD and decision making regarding dialysis. | ||||||
| Pugh-Clarke, K. 2017 [ | United Kingdom | 18 | 65b (SD: 13.21) | 9/9 | x | x | Convenience | Interview (semi-structured) | Thematic analysis | Symptom experience in CKD stage 4 and 5 | |||||
| Campbell-Crofts, S. 2018 [ | Australia | 12 | - (range 31–81) | 4/8 | x | x | x | Convenience | Interview (semi-structured) | Thematic analysis | Views on decision making regarding KRT in late stage CKD | ||||
Overview of the major themes and subthemes with illustrative quotations
| Theme | Illustrative quotations |
|---|---|
| Pursuing normality and control | 1) ● ● ● 2) ● ● ● |
| Prioritizing outcomes | 1) ● ● ● 2) ● ● ● 3) ● ● ● 4) ● ● ● |
| Predicting the future | ● ● ● |
| Realising what matters | ● ● ● |
Fig. 2Thematic schema: an overview of the identified themes with a hypothesized relation between themes. Patients with CKD face uncertainties and problems regarding their disease progress. This is aggravated by the lack of knowledge, incomprehensible and unavailable information and impossibility to adequately estimate risks, essentially leaving patients in a situation where they do not know what to expect, how high the risks are, and when to expect certain outcomes of interest. Major themes (blue boxes, bold) are linked to subthemes (white boxes, underlined). Abbreviations: CKD; chronic kidney disease, KRT; kidney replacement therapy
Fig. 3COREQ quality of reporting summary of the 46 included studies, over the three domains (domain 1: ‘research team and reflexivity’, comprises 8 signalling questions which describes both the personal characteristics of the researchers and their relationships with the participants; domain 2: ‘study design’ comprises 15 questions which describes the included population and study methods; and domain 3: ‘analysis and findings’, comprises 9 questions which describes the analysis and clarity of the results) containing a total of 32 signalling questions. An overview of each individual study is presented in the supplementary Table S2